Antibodies and Immunology News and Research

Latest Antibodies and Immunology News and Research

Specialist assay kits and microplates for cancer research

Porvair Sciences will exhibit its latest assay kits and microplates for cancer and life science research at the American Association for Cancer Research (AACR) meeting in New Orleans, USA from the 8th – 13th April 2022.

From Porvair Sciences Limited 7 Apr 2022

Transposons are a potential antibiotic resistance, a study reveals

According to biomedical engineers at Duke University, the physical mechanism that enables high doses of antibiotics to encourage the transmission of antibiotic resistance across bacteria is now identified.

7 Apr 2022

A critical subset of supporting cells may lie at the origins of scleroderma

Supporting actors sometimes steal the show. In a new study published today in Cell, researchers headed by Prof. Ido Amit at the Weizmann Institute of Science have shown that supporting cells called fibroblasts, long viewed as uniform background players, are in fact extremely varied and vital.

5 Apr 2022

Checkpoint immunotherapy acts as an interface between killer T cells and dendritic cells

Chronic viral infections and cancers can damage the immune system permanently, diminishing the ability of immune killer T cells to destroy tumor cells or virus-infected cells—a condition known as “immune exhaustion.”

5 Apr 2022

Plant compound may be a good therapeutic candidate for treating food allergies

Researchers combined advanced computational methods with experimental studies to gain new insight, at the cell level, into how the plant compound formononetin might be used to treat food allergies.

4 Apr 2022

Noncoding DNA mutations prevent the brain from amyotrophic lateral sclerosis

When a condition is connected to a genetic mutation, it is generally negative news.

4 Apr 2022

Researchers discover a unique technique to fight hospital-borne disease

A study team developed an early-stage therapy that sabotages the pump and restores antibiotic efficiency by disclosing the structure of a protein needed by bacteria to pump out antibiotics.

From New York University (NYU) 4 Apr 2022

Light-induced cellular apoptosis method can kill diseased cells without causing adverse reactions

Cancer has been the leading cause of death in Japan over the past 40 years. Despite the rise in patients due to the aging population, progresses in diagnosis and treatment are leading to higher survival rates.

1 Apr 2022

Researchers focus to create a new class of molecules for curing biofilm infections

Chronic skin wounds are a rising global issue among the elderly, individuals with severe burns, and people with underlying medical diseases such as diabetes.

1 Apr 2022

Study helps to make sense of cell-to-cell variation in response to external stimuli

Why do genetically similar cells react to the same extrinsic stimuli, such as antibiotics, in such diverse ways?

1 Apr 2022

Researchers discover a novel pathway for DNA transfer in the tumor microenvironment

Scientists from the University of Notre Dame have found a new way for tumor cells to transmit genetic material to other cells in their microenvironment, allowing cancer to spread.

1 Apr 2022

Killifish study finds age-dependent loss of antibody diversity

As we age, our immune system works less well. We become more susceptible to infections and vaccinations no longer work as effectively.

29 Mar 2022

Multiple nanobodies effectively block infection with different SARS-CoV-2 variants

Researchers at Karolinska Institutet in Sweden have developed a novel strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging SARS-CoV-2 variants.

28 Mar 2022

Study reveals why infected individuals cannot get rid of HIV altogether

Thanks to antiretroviral therapy, HIV infection is no longer the life sentence it once was. But despite the effectiveness of drugs to manage and treat the virus, it can never be fully eliminated from the human body, lingering in some cells deep in different human tissues where it goes unnoticed by the immune system.

28 Mar 2022

Scientists create powerful new method for generating protein drugs

A team of scientists has created a powerful new method for generating protein drugs. Using computers, they designed molecules that can target important proteins in the body, such as the insulin receptor, as well as vulnerable proteins on the surface of viruses.

28 Mar 2022

CDH17CAR T cells can eliminate solid tumors without damaging healthy tissues

Chimeric antigen receptor (CAR) T cells can be remarkably effective in treating leukemias and lymphomas, but there are no successful immunotherapies for neuroendocrine tumors (NETs) and gastrointestinal cancers (GICs) yet.

25 Mar 2022

CAR-T cell treatment via implantable biotechnology more effective in combating cancer

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

25 Mar 2022

Hybrid immunity generates improved cell response to fight SARS-CoV-2 infections

People who were infected with SARS-CoV-2 before being vaccinated generate an immune response more specific to fighting viral infections, and produce a broader antibody response, than do people whose only protection is the vaccine, according to researchers at the University of Washington School of Medicine.

25 Mar 2022

Researchers determine novel technique for drug delivery

They have devised a novel means of delivering medicines and peptides into cells.

25 Mar 2022

Novel protein Atossa regulates cell invasion

Researchers from the Institute of Science and Technology Austria have found a novel protein that stimulates energy generation inside immune cells, allowing them to penetrate more effectively.

24 Mar 2022

Antibodies and Immunology News and Research

Latest Antibodies and Immunology News and Research

Specialist assay kits and microplates for cancer research

Transposons are a potential antibiotic resistance, a study reveals

A critical subset of supporting cells may lie at the origins of scleroderma

Checkpoint immunotherapy acts as an interface between killer T cells and dendritic cells

Plant compound may be a good therapeutic candidate for treating food allergies

Noncoding DNA mutations prevent the brain from amyotrophic lateral sclerosis

Researchers discover a unique technique to fight hospital-borne disease

Light-induced cellular apoptosis method can kill diseased cells without causing adverse reactions

Researchers focus to create a new class of molecules for curing biofilm infections

Study helps to make sense of cell-to-cell variation in response to external stimuli

Researchers discover a novel pathway for DNA transfer in the tumor microenvironment

Killifish study finds age-dependent loss of antibody diversity

Multiple nanobodies effectively block infection with different SARS-CoV-2 variants

Study reveals why infected individuals cannot get rid of HIV altogether

Scientists create powerful new method for generating protein drugs

CDH17CAR T cells can eliminate solid tumors without damaging healthy tissues

CAR-T cell treatment via implantable biotechnology more effective in combating cancer

Hybrid immunity generates improved cell response to fight SARS-CoV-2 infections

Researchers determine novel technique for drug delivery

Novel protein Atossa regulates cell invasion

Immunology eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Antibodies and Immunology News and Research

Latest Antibodies and Immunology News and Research

Immunology eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Newsletters you may be interested in